GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Yatai Pharmaceutical Co Ltd (SZSE:002370) » Definitions » EV-to-Revenue

Zhejiang Yatai Pharmaceutical Co (SZSE:002370) EV-to-Revenue : 4.17 (As of Jun. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zhejiang Yatai Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Zhejiang Yatai Pharmaceutical Co's enterprise value is ¥1,709.6 Mil. Zhejiang Yatai Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥409.8 Mil. Therefore, Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue for today is 4.17.

The historical rank and industry rank for Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

SZSE:002370' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.71   Med: 7.58   Max: 17.16
Current: 4.17

During the past 13 years, the highest EV-to-Revenue of Zhejiang Yatai Pharmaceutical Co was 17.16. The lowest was 3.71. And the median was 7.58.

SZSE:002370's EV-to-Revenue is ranked worse than
72.63% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.26 vs SZSE:002370: 4.17

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-05), Zhejiang Yatai Pharmaceutical Co's stock price is ¥2.76. Zhejiang Yatai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.68. Therefore, Zhejiang Yatai Pharmaceutical Co's PS Ratio for today is 4.04.


Zhejiang Yatai Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Yatai Pharmaceutical Co EV-to-Revenue Chart

Zhejiang Yatai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.68 4.13 8.12 7.59 6.14

Zhejiang Yatai Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.26 5.63 6.21 6.14 5.20

Competitive Comparison of Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue falls into.



Zhejiang Yatai Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1709.553/409.771
=4.17

Zhejiang Yatai Pharmaceutical Co's current Enterprise Value is ¥1,709.6 Mil.
Zhejiang Yatai Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥409.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Yatai Pharmaceutical Co  (SZSE:002370) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Zhejiang Yatai Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.76/0.684
=4.04

Zhejiang Yatai Pharmaceutical Co's share price for today is ¥2.76.
Zhejiang Yatai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Yatai Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zhejiang Yatai Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Yatai Pharmaceutical Co (SZSE:002370) Business Description

Traded in Other Exchanges
N/A
Address
No. 1152, Yunji Road, Keqiao District, Zhejiang province, Shaoxing, CHN, 312030
Zhejiang Yatai Pharmaceutical Co Ltd is a China-based company engaged in the research, production, and sales of pharmaceutical drugs. Its product portfolio includes tablets, hard capsules, transdermal patches, freeze-dried powder injections, powder injections, azithromycin, roxithromycin and other products. The company sells its products both in China and other international countries.
Executives
Wang Li Yun Executives
Zhong Wan Zhen Director
Lv Xu Xing Director
Shen Yi Yi Directors, Directors, and Executives
He Zhen Directors, executives
Zhu Feng Securities Affairs Representative
Ren Jun Director
Ping Hua Biao Director
Chen Yao Gen Directors, executives

Zhejiang Yatai Pharmaceutical Co (SZSE:002370) Headlines

No Headlines